CONCORD BIOTECH
Back to Balance Sheet
|
CONCORD BIOTECH Last 5 Year Sundry Debtors History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹522 Cr | ₹350 Cr | ₹274 Cr | ₹232 Cr | ₹178 Cr |
What is the latest Sundry Debtors ratio of CONCORD BIOTECH ?
| Year | Sundry Debtors |
|---|---|
| Mar2025 | ₹522 Cr |
| Mar2024 | ₹350 Cr |
| Mar2023 | ₹274 Cr |
| Mar2022 | ₹232 Cr |
| Mar2021 | ₹178 Cr |
How is Sundry Debtors of CONCORD BIOTECH Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2025 | ₹522 Cr | 49.21 | |
| Mar2024 | ₹350 Cr | 27.71 | |
| Mar2023 | ₹274 Cr | 17.91 | |
| Mar2022 | ₹232 Cr | 30.79 | |
| Mar2021 | ₹178 Cr | - | |
Compare Sundry Debtors of peers of CONCORD BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CONCORD BIOTECH | ₹14,161.3 Cr | 13.1% | 19.7% | -30.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹433,620.0 Cr | 1% | -0.9% | 6.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹176,087.0 Cr | 1.8% | -2.3% | 1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹154,837.0 Cr | 3.7% | 6.5% | 44.9% | Stock Analytics | |
| CIPLA | ₹112,194.0 Cr | 0% | 4.7% | -8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,328.0 Cr | -0.2% | 0.7% | -3.4% | Stock Analytics | |
CONCORD BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CONCORD BIOTECH | 13.1% |
19.7% |
-30.2% |
| SENSEX | 1.7% |
1.3% |
-7.3% |
You may also like the below Video Courses